APN/CD13 expression on the lung cancer cell lines by flow cytometry analysis and RT-PCR
| NSCLC . | FACS . | RT-PCR . | SCLC . | FACS . | RT-PCR . |
|---|---|---|---|---|---|
| LCMS (AD) | S | P | SBC1 (SCLC) | W | N |
| MAC10 (AD) | S | P | SBC2 (SCLC) | W | N |
| PC9 (AD) | S | P | SBC3 (SCLC) | W | N |
| PC14 (AD) | S | P | SBC5 (SCLC) | W | N |
| A549 (AD) | W | N | MOA1P23 (SCLC) | W | N |
| HAL8 (AD) | W | N | LU135 (SCLC) | W | N |
| HAL24 (AD) | W | N | LU139 (SCLC) | W | N |
| ABC1 (AD) | W | N | N417 (SCLC) | W | N |
| LC-2/ad (AD) | W | N | Lawson (SCLC) | W | N |
| LC-1/sq (SQ) | W | N | SCLC-Mo (SCLC) | W | N |
| EBC1 (SQ) | W | N | LCMA (SCLC) | M | P |
| LC-TK (SQ) | W | N | |||
| LC1F (SQ) | W | N | |||
| AOI (SQ) | W | N | |||
| EHHSQ13 (SQ) | W | N | |||
| LK-1 (SQ) | W | N |
| NSCLC . | FACS . | RT-PCR . | SCLC . | FACS . | RT-PCR . |
|---|---|---|---|---|---|
| LCMS (AD) | S | P | SBC1 (SCLC) | W | N |
| MAC10 (AD) | S | P | SBC2 (SCLC) | W | N |
| PC9 (AD) | S | P | SBC3 (SCLC) | W | N |
| PC14 (AD) | S | P | SBC5 (SCLC) | W | N |
| A549 (AD) | W | N | MOA1P23 (SCLC) | W | N |
| HAL8 (AD) | W | N | LU135 (SCLC) | W | N |
| HAL24 (AD) | W | N | LU139 (SCLC) | W | N |
| ABC1 (AD) | W | N | N417 (SCLC) | W | N |
| LC-2/ad (AD) | W | N | Lawson (SCLC) | W | N |
| LC-1/sq (SQ) | W | N | SCLC-Mo (SCLC) | W | N |
| EBC1 (SQ) | W | N | LCMA (SCLC) | M | P |
| LC-TK (SQ) | W | N | |||
| LC1F (SQ) | W | N | |||
| AOI (SQ) | W | N | |||
| EHHSQ13 (SQ) | W | N | |||
| LK-1 (SQ) | W | N |
Abbreviations: AD, adenocarcinoma; SQ, squamous cell carcinoma; LA, large cell carcinoma; W, weak (<20%); M, moderate (21-60%); S, strong (>61%); N, negative; P, positive; FACS, fluorescence-activated cell sorting analysis.